ReviewCost effectiveness and resource allocation : C/E2019

Abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer in China: an indirect treatment comparison and cost analysis.

Xin Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.